Welcome to CeNeS Pharmaceuticals plc. Our mission is to discover and develop treatments for disorders related to the Central Nervous System, particularly in the areas of pain, anaesthesia and neurology.

CeNeS aims to build a profitable, European speciality pharmaceutical company by developing, partnering and marketing a portfolio of new pharmaceutical products which offer significant improvements over the existing ‘gold standard’ treatments.

CeNeS has considerable experience in developing CNS and pain products up to clinical proof of concept and beyond.

Our share price details can be obtained from the London Stock Exchange (AIM)